AU2001276306A1 - Use of dicalcium phosphate anhydride powder - Google Patents

Use of dicalcium phosphate anhydride powder

Info

Publication number
AU2001276306A1
AU2001276306A1 AU2001276306A AU7630601A AU2001276306A1 AU 2001276306 A1 AU2001276306 A1 AU 2001276306A1 AU 2001276306 A AU2001276306 A AU 2001276306A AU 7630601 A AU7630601 A AU 7630601A AU 2001276306 A1 AU2001276306 A1 AU 2001276306A1
Authority
AU
Australia
Prior art keywords
dicalcium phosphate
phosphate anhydride
anhydride powder
mum
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276306A
Inventor
Erhard Fischer
Silke Geb. Kratzmann John
Stefan Mallmann
Jurgen Meven
Gerhard Scheuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemische Fabrik Budenhiem KG
Original Assignee
Chemische Fabrik Budenhiem KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemische Fabrik Budenhiem KG filed Critical Chemische Fabrik Budenhiem KG
Publication of AU2001276306A1 publication Critical patent/AU2001276306A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Dicalcium phosphate anhydride powder of which at least 50% by weight is of a grain size of between 45 and 150 mum, a maximum of 50% by weight is of a grain size of <45 mum and a maximum of 5% by weight is of a grain size >150 mum and which has a bulk density of between 1000 and 1500 g/l and a specific surface area of <5 m2/g is used for direct tabletting or capsule filling of pharmaceutical preparations.
AU2001276306A 2000-07-04 2001-06-29 Use of dicalcium phosphate anhydride powder Abandoned AU2001276306A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10032434A DE10032434A1 (en) 2000-07-04 2000-07-04 Use of dicalcium phosphate anhydride powder
DE10032434 2000-07-04
PCT/DE2001/002484 WO2002002082A2 (en) 2000-07-04 2001-06-29 Use of dicalcium phosphate anhydride powder

Publications (1)

Publication Number Publication Date
AU2001276306A1 true AU2001276306A1 (en) 2002-01-14

Family

ID=7647722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276306A Abandoned AU2001276306A1 (en) 2000-07-04 2001-06-29 Use of dicalcium phosphate anhydride powder

Country Status (8)

Country Link
US (2) US7691410B2 (en)
EP (1) EP1296654B1 (en)
AT (1) ATE334661T1 (en)
AU (1) AU2001276306A1 (en)
CA (1) CA2413578C (en)
DE (2) DE10032434A1 (en)
DK (1) DK1296654T3 (en)
WO (1) WO2002002082A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8375896B2 (en) 2010-10-14 2013-02-19 Gaines B. Slade, JR. Method of use of dicalcium phosphate as an antler scent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2220474A1 (en) * 1973-03-09 1974-10-04 Ugine Kuhlmann Highly absorbent calcium phosphate for animal feeds - in the form of granules or compacted grains of specified porosity
DE3347476A1 (en) * 1982-12-29 1984-07-05 Lion Corp., Tokio / Tokyo DENTAL CARE AND SUITABLE ABRASIVE
US4707361A (en) * 1985-08-02 1987-11-17 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4721615A (en) * 1986-05-05 1988-01-26 Monsanto Company Calcium phosphates
JPS63103809A (en) * 1986-10-22 1988-05-09 Agency Of Ind Science & Technol Production of porous calcium phosphate sphere
US5055307A (en) * 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
DE4122960C2 (en) * 1991-07-11 1994-03-31 Benckiser Knapsack Ladenburg Process for the preparation of coarse-grained dicalcium phosphate anhydride
JP2700141B2 (en) * 1993-09-17 1998-01-19 富士化学工業株式会社 Calcium hydrogen phosphate, its production method and excipient using the same
KR20010012402A (en) * 1997-05-09 2001-02-15 세이지 파마슈티칼스, 인크. Stable oral pharmaceutical dosage forms
EP1008353A1 (en) * 1998-04-24 2000-06-14 Fuji Chemical Industry Co., Ltd. Saccharide-containing compositions
WO2003055418A1 (en) * 2001-12-21 2003-07-10 Lagow Richard J Calcium phosphate bone replacement materials and methods of use thereof
US7364755B2 (en) * 2003-07-07 2008-04-29 Synthon Ip Inc. Modified calcium phosphate excipient

Also Published As

Publication number Publication date
ATE334661T1 (en) 2006-08-15
EP1296654B1 (en) 2006-08-02
DE10032434A1 (en) 2002-01-24
CA2413578C (en) 2009-02-10
EP1296654A2 (en) 2003-04-02
CA2413578A1 (en) 2002-01-10
WO2002002082A2 (en) 2002-01-10
US20100144894A1 (en) 2010-06-10
US8501235B2 (en) 2013-08-06
DK1296654T3 (en) 2006-08-28
WO2002002082A3 (en) 2002-06-27
US7691410B2 (en) 2010-04-06
DE50110628D1 (en) 2006-09-14
US20040013724A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
HUP0203841A3 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
AU5936400A (en) Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
HK1037975A1 (en) Two-piece capsule for receiving pharmaceutical preparations for powder inhalers.
CA2294783A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
CA2292673A1 (en) Pharmaceutical compositions containing eletriptan hemisulphate
TW280774B (en)
HUP0203376A3 (en) 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them and their use
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
CA2000763A1 (en) Dispersable formulation
HUP0003207A3 (en) Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
AU2001276306A1 (en) Use of dicalcium phosphate anhydride powder
CA2250191A1 (en) Benzothiophenes, formulations containing same, and methods
AU4531499A (en) Fine powder of l-alpha-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
AU4929400A (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
CA2255064A1 (en) Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
BG106151A (en) Pharmaceutical complex
AU4483693A (en) Solid oral tablet formulations of ifosfamide
PL345309A1 (en) Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
AU3416995A (en) Endothelin receptor antagonists
CA2382359A1 (en) Pharmaceutical preparation containing nanosol